ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Translational Session

The Renal Allograft Biopsy and Next-Generation Clinical Trials

November 08, 2019 | 02:00 PM - 04:00 PM

Location: 201, Walter E. Washington Convention Center

Session Description

The renal biopsy assessment is a critical element to address therapeutic intervention. Morphologic analysis paired with molecular approaches has the potential to better characterize transplant patients and guide therapy. This session explores the relevant elements to developing personalized medicine in kidney transplantation and improving transplant patient outcomes. Particular emphasis is given to novel approaches for monitoring disease status, predicting outcome, and defining early surrogate end points that might aid clinical decision-making.

Learning Objective(s)

  • Discuss relevant morphologic findings in transplanted kidneys
  • Describe diagnostic criteria and the biomarkers of rejection
  • Identify new strategies for patient categorization and therapeutic approaches

Learning Pathway(s)

  • Pathology
  • Transplantation/Immunology


  • Ibrahim Batal, MD
  • Banu Sis, MD


  • Interstitial Fibrosis and Tubular Atrophy (IFTA), i-IFTA, and the Response to Injury
    02:00 PM - 02:30 PM
    Mark Haas, MD, PhD 
  • An Integrated Prediction Score of Allograft Survival
    02:30 PM - 03:00 PM
    Alexandre Loupy, MD
  • Gene Expression Profiling and Histologic and Noninvasive Biomarkers in Antibody-Mediated Rejection
    03:00 PM - 03:30 PM
    Carmen Lefaucheur, MD, PhD
  • Precision Diagnostic and Next-Generation Clinical Trials
    03:30 PM - 04:00 PM
    Michael Mengel, MD